SCHEMBL4677964

SCHEMBL4677964

CCOC(=O)CCC(C)(C)c1ccc(S(=O)(=O)Cl)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.41
GAA P10253 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
MEN1 O00255 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39
POLB P06746 3/20 0.39
HSD11B1 P28845 1/20 0.39
CYP4F2 P78329 2/20 0.37
CYP4A11 Q02928 2/20 0.37
ALDH1A1 P00352 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
LMNA P02545 2/20 0.36
S1PR4 O95977 1/20 0.36
TP53 P04637 1/20 0.36
HPGD P15428 1/20 0.36
S1PR1 P21453 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1809731 0.82 GRIN2D (0.49) KMT2AGAAMEN1CNR1CNR2
SCHEMBL3486832 0.82 CNR1 (0.47) KMT2AMEN1CNR1CNR2POLB
SCHEMBL3485782 0.80 SMN1; SMN2 (0.41) L3MBTL1CNR1CNR2POLBCYP4F2
SCHEMBL4677396 0.80 CNR1 (0.42) GAACNR1CNR2POLBCYP4F2
SCHEMBL1831814 0.80 KMT2A (0.45) KMT2AGAANPSR1MEN1L3MBTL1
SCHEMBL3486385 0.78 POLB (0.44) KMT2AMEN1L3MBTL1CNR1CNR2
SCHEMBL6292770 0.77 RORC (0.55) KMT2AGAANPSR1MEN1CNR2
SCHEMBL10249055 0.74 CCR9 (0.50) KMT2AGAAMEN1POLBHSD11B1
SCHEMBL344370 0.73 NPC1 (0.43) CNR2POLBHSD11B1ALDH1A1SMN1; SMN2
SCHEMBL119585 0.73 LMNA (0.54) KMT2AGAANPSR1POLBCYP4F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1482935-B1 THIAZOLE AND OXAZOLE DERIVATIVES WHICH MODULATE PPAR ACTIVITY WARNER LAMBERT CO (US) 2008-08-20 EP disclosed
EP-1482935-A1 THIAZOLE AND OXAZOLE DERIVATIVES WHICH MODULATE PPAR ACTIVITY Warner-Lambert Company LLC (US) 2004-12-08 EP disclosed
US-20030207924-A1 Compounds that modulate PPAR activity and methods of preparation CHENG XUE-MIN (US) 2003-11-06 US disclosed
WO-2003074050-A1 THIAZOLE AND OXAZOLE DERIVATIVES WHICH MODULATE PPAR ACTIVITY WARNER-LAMBERT COMPANY LLC (US) 2003-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030207924-A1 Compounds that modulate PPAR activity and methods of preparation PPARA, PPARD, PPARG KMT2A 2302/4885GAA 858/4885NPSR1 1418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.